Skip to main content

Table 3 Impact of neoadjuvant chemotherapy on healthy tissue (PP)

From: Metabolomics approaches in pancreatic adenocarcinoma: tumor metabolism profiling predicts clinical outcome of patients

Metabolite

Neoadjuvant chemotherapy

Mean (nmol/mg)

p value

Ascorbate

No

0.3488 ± 0.2191

0.6730

Yes

0.3592 ± 0.1671

Aspartic acid

No

0.7577 ± 0.3284

0.9626

Yes

0.6730 ± 0.1776

Choline

No

1.5580 ± 0.5921

0.7430

Yes

1.7649 ± 0.7624

Creatine

No

1.7371 ± 0.9568

0.5414

Yes

1.7760 ± 0.6579

Ethanolamine

No

0.9314 ± 0.4502

0.6058

Yes

1.1115 ± 0.5408

Glutamate

No

2.9830 ± 0.8698

0.8148

Yes

2.3800 ± 0.4264

Glycerol

No

8.1840 ± 7.3988

0.6730

Yes

8.2990 ± 7.2904

Glycine

No

6.0920 ± 5.0908

0.5414

Yes

6.5590 ± 5.7401

Glycerophosphocholine

No

2.4215 ± 2.6084

0.9626

Yes

2.2208 ± 2.1689

Lactate

No

11.0040 ± 2.4733

0.3704

Yes

9.6770 ± 2.1588

Phosphorylcholine

No

1.1690 ± 0.6396

0.8148

Yes

0.9469 ± 0.3644

Taurine

No

2.9660 ± 1.9594

0.9626

Yes

2.7060 ± 1.3103

Threonine

No

1.1202 ± 0.2821

0.6730

Yes

1.1678 ± 0.2801

Glutamine

No

0.6855 ± 0.2518

0.5414

Yes

0.5633 ± 0.1466

Succinic acid

No

0.3069 ± 0.2121

0.8884

Yes

0.2595 ± 0.1406

Glucose

No

1.2247 ± 0.6158

0.4807

Yes

1.0736 ± 0.7355

Tyrosine

No

0.0520 ± 0.0442

0.6058

Yes

0.0552 ± 0.0599

Phenylalanine

No

0.1449 ± 0.0771

0.8148

Yes

0.1495 ± 0.0880

  1. Results of the Mann-Whitney U test. Metabolite differences between PP without neoadjuvant chemotherapy and PP with neoadjuvant chemotherapy (univariate analysis, nonparametric test)